| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |